Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
-
1001
Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia...
Published 2025Subjects: “…treatment initiation decreased…”
-
1002
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
Published 2025Subjects: “…treatment initiation decreased…”
-
1003
Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later.
Published 2025Subjects: “…treatment initiation decreased…”
-
1004
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
Published 2025Subjects: “…treatment initiation decreased…”
-
1005
General information of patient who diagnosis insomnia disorder (N = 518,119).
Published 2025Subjects: “…treatment initiation decreased…”
-
1006
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
Published 2025Subjects: “…treatment initiation decreased…”
-
1007
Treatment at first diagnosis of insomnia disorder (%).
Published 2025Subjects: “…treatment initiation decreased…”
-
1008
Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).
Published 2025“…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”
-
1009
-
1010
Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress.
Published 2025“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”
-
1011
Design of the D-trial.
Published 2024“…An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
-
1012
Estimated mean values for light interception.
Published 2024“…An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
-
1013
Raw data V-trial.
Published 2024“…An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
-
1014
Raw data D-trial.
Published 2024“…An increase in PD led to a linear decrease in inflorescence yield per plant (<i>p</i> = 0.02), whereas a positive linear relationship was found for inflorescence yield (<i>p</i> = 0.0001) and CBD yield (<i>p</i> = 0.0002) per m<sup>2</sup>. …”
-
1015
-
1016
-
1017
-
1018
-
1019
-
1020